Memantine Hydrochloride Activase Pharmaceuticals

Memantine Hydrochloride, the active ingredient in Memantine Hydrochloride Activase Pharmaceuticals, is an NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of Alzheimer’s disease in adult patients. GNH USA supplies Memantine Hydrochloride Activase Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Memantine Hydrochloride is used in the management of Alzheimer’s disease, a neurodegenerative disorder affecting cognition and daily function. Alzheimer's disease: helps maintain cognitive function and daily living abilities in patients with mild‑to‑moderate or moderate‑to‑severe disease.

Memantine Hydrochloride may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Constipation: reduced bowel movements or hard stools. - Fatigue: feeling unusually tired or weak. - Confusion: transient difficulty concentrating. - Hypertension: elevated blood pressure readings.

Serious or Rare Side Effects: - Seizures: uncontrolled convulsive episodes. - Hallucinations: visual or auditory disturbances. - Cardiac arrhythmia: irregular heart rhythm. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts: emergence of depressive ideation. - Hepatic injury: abnormal liver function tests.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Renal impairment: adjust dose or avoid use in severe dysfunction. - History of seizures: monitor closely for increased seizure activity. - Cardiovascular disease: observe blood pressure and heart rhythm. - Concurrent NMDA antagonists: avoid combined use to reduce neurotoxicity risk. - Pregnancy and breastfeeding: safety not established; use only if benefit outweighs risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Memantine may interact with other medications that affect the central nervous system or share similar pathways.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase neurotoxicity. - Ketamine: combined CNS depression and potential respiratory depression. - Other NMDA antagonists: risk of excessive blockade.

Moderate Interactions (Monitor Closely): - Anticholinergics: may diminish therapeutic benefit. - Diuretics: possible enhancement of hypotensive effects. - CNS depressants (e.g., benzodiazepines): monitor for increased sedation.